Ignite Creation Date:
2025-12-24 @ 1:35 PM
Ignite Modification Date:
2025-12-30 @ 4:36 PM
Study NCT ID:
NCT05447195
Status:
UNKNOWN
Last Update Posted:
2022-07-12
First Post:
2022-06-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of CAN008 in Subjects With GBM
Sponsor:
CANbridge Life Sciences Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-17
First Submit QC Date:
None
Study First Post Date:
2022-07-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-10
Last Update Post Date:
2022-07-12
Last Update Post Date Type:
ACTUAL